Dr. Yaszemski is a professor of biomedical engineering at the Mayo Clinic in Rochester, Minn., and director of its biomaterials and tissue engineering laboratory. He previously served as chair of the FDA Center for Devices and Radiologic Health Advisory Committee and is a current member of the FDA Science Board.
He is retired U.S. Air Force brigadier general and served in the office of the Air Force Surgeon General and the office of the president of the Uniformed Services University of the Health Sciences in Bethesda, Md., before retiring in 2013.
Dr. Yaszemski earned both is bachelor’s and master’s degrees in chemical engineering from Lehigh University in Bethlehem, Pa., his medical degree from Georgetown University in Washington, D.C., and a PhD in chemical engineering from the Massachusetts Institute of Technology in Cambridge, Mass.
Chris Mason, PhD, co-founder and chief science officer at gene-therapy company AvroBio based in Cambridge, Mass., will also be joining Dr. Yaszemski on the BioBridge board.
More articles on biologics:
Misonix acquires Solys Medical for $97M — 5 Takeaways
UNC, NC State scientists collaborate to print human body tissues
Expesicor, Novoron Bioscience to collaborate on treatment for central nervous system disorders
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
